27 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... 3 years • Co-testing ... (Pap test and HPV ... HumanPapillomavirus #IDSA ... infections #HIVAIDS #pharmacology
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
susceptibility testing ... #IDSA #Meningitis ... InfectiousDiseases #Pharmacology
Group A Strep Pharyngitis, also known as  Strep Throat. 

In addition to symptomatic presentation, a
antigen detection test ... retail/community setting ... recommended by IDSA ... That's because this test ... penicillin allergy testing
Helicobacter Pylori Testing  Methods - Sensitivity and Specificity

Serology - 85% - 79% - Does not
Helicobacter Pylori Testing ... other means of testing ... Urea breath test ... first line test ... or unexplained IDA
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... Preventing and Treating ... Preferred Therapy for Treating ... Enteric #Bacterial #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Preventing and Treating ... Treating Acute Infection ... Penicilliosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Preventing and Treating ... Chagas disease Treating ... Trypanosomiasis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for Treating Mucosal ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... for Treating Visceral ... Leishmaniasis in HIV-AIDS Treating ... every 21 days Treating ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... for Treating Isospora ... Infection in HIV-AIDS Treating ... IsosporaBelli #IDSA ... infections #HIVAIDS #pharmacology